Lateral flow immunoassay development services
Cytiva Diagnostic Services: accelerate rapid point-of-care immunoassay development
Immunoassay Development Services
Immunoassay development services are part of Cytiva Diagnostic Services which provide early stage developers access to our point-of-care lateral flow expertise, infrastructure and proven development methodologies.
Discover
Discover how Cytiva Diagnostic Services enables early-stage developers to convert their idea or lab-based test to a rapid diagnostic test successfully, with support at every stage, from concept to prototype.
Read more
Case study: Ubique Bio
Ubique Bio were the winners of the Dx Challenge in 2022 and benefited from a 3-day workshop at the Cytiva site in Dassel, Germany hoping to find the best way to incorporate synthetic peptides into a test strip and find the most efficient way to multiplex the strip.
"Cytiva experts added significant value to our ideas giving us a clearer perspective to our objectives and future directions."
Angelita Lorenzo
Ubique Bio, Co-Founder and Chief Science Officer
Case study: Hutano Diagnostics
Hutano Diagnostics recently completed a 3-day workshop with Cytiva Diagnostic Services to advance their rapid Ebola point-of-care test.
"The work that we have been doing here has helped us to reshape our R&D strategy and to become more efficient. [It] has saved us months of development."
Atherton Mutambwera
Hutano Diagnostics, Founder, CEO
